Biomaterial Database

Donor dopamine pretreatment and graft function after kidney transplantation. 2010

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

UI	MeSH Term	Description	Entries
D007677	Kidney Function Tests	Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine.	Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D009926	Organ Preservation	The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).	Organ Preservations,Preservation, Organ,Preservations, Organ
D004298	Dopamine	One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.	Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006435	Renal Dialysis	Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.	Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203	Reproducibility of Results	The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.	Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015259	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.	Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic
D016030	Kidney Transplantation	The transference of a kidney from one human or animal to another.	Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016032	Randomized Controlled Trials as Topic	Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.	Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D055031	Primary Graft Dysfunction	A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.	Dysfunction, Primary Graft,Graft Dysfunction, Primary

Related Publications

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Donor dopamine pretreatment and graft function after kidney transplantation.

January 2010, JAMA,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Donor dopamine pretreatment and graft function after kidney transplantation.

January 2010, JAMA,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.

September 2009, JAMA,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Impact of donor dopamine on immediate graft function after kidney transplantation.

March 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial.

March 2017, Clinical journal of the American Society of Nephrology : CJASN,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Delayed Graft Function 5 Months After Living Donor Kidney Transplantation.

February 2016, The American journal of case reports,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Early graft function after laparoscopically procured living donor kidney transplantation.

October 2010, The Journal of urology,

Dan Ridgway, and Jenifer Barrie, and Krishnan Menon

Donor pretreatment with dopamine and graft function following kidney transplant: a strategy to improve transplant outcomes?

July 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation,